Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum

Adhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed...

Full description

Bibliographic Details
Main Authors: L. Moura, J. Dohms, J.M. Almeida, P.S. Ferreira, C.P. Biffi, R.G. Backes
Format: Article
Language:English
Published: Universidade Federal de Minas Gerais 2012-12-01
Series:Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352012000600024&lng=en&tlng=en
id doaj-ed5194b363324bf7a95dd359748e7471
record_format Article
spelling doaj-ed5194b363324bf7a95dd359748e74712020-11-25T01:30:07ZengUniversidade Federal de Minas GeraisArquivo Brasileiro de Medicina Veterinária e Zootecnia1678-41622012-12-016461569157610.1590/S0102-09352012000600024S0102-09352012000600024Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticumL. Moura0J. Dohms1J.M. Almeida2P.S. Ferreira3C.P. Biffi4R.G. Backes5Universidade do Estado de Santa CatarinaDelaware UniversityUniversidade do Estado de Santa CatarinaUniversidade do Estado de Santa CatarinaUniversidade do Estado de Santa CatarinaUniversidade do Estado de Santa CatarinaAdhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed into an oil emulsion creating a novel MG vaccine. Six different protein concentrations (50, 100, 200, 400, 800, and 1000µg/bird) were tested with two equal concentration doses at four and seven weeks of age. In addition, many control groups were needed such as bacterin, membrane, no vaccine or challenge, oil emulsion alone, and no vaccine but challenged. Three weeks following the second vaccination, 50% of the birds in each treatment group were challenged with MG strain S6. The remaining birds were left as contacts to verify protection against horizontal transmission. All birds were bled before vaccinations, challenge and euthanasia. Birds were negative for MG at the first vaccination, as shown by serum plate agglutination test. At necropsy, tissue samples (trachea, lungs, and air sacs) were collected for histopathological examination. Swabs from trachea were used for PCR analysis. ELISA results showed a strong immune response to both protein preparations and almost the same response level for different doses tested, proving the immunogenic features of MGC1 and MGC2. However, humoral responses failed to prevent MG infection and disease when challenged as demonstrated by PCR and histopathology. MGC1 contact birds showed some degree of infection by PCR analysis. In addition, histopathological and ELISA results suggest that contact birds did not have enough time to develop lesions and to mount an immune response.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352012000600024&lng=en&tlng=enavaliaçãoaviculturadesenvolvimentomicoplasmasvacina
collection DOAJ
language English
format Article
sources DOAJ
author L. Moura
J. Dohms
J.M. Almeida
P.S. Ferreira
C.P. Biffi
R.G. Backes
spellingShingle L. Moura
J. Dohms
J.M. Almeida
P.S. Ferreira
C.P. Biffi
R.G. Backes
Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
Arquivo Brasileiro de Medicina Veterinária e Zootecnia
avaliação
avicultura
desenvolvimento
micoplasmas
vacina
author_facet L. Moura
J. Dohms
J.M. Almeida
P.S. Ferreira
C.P. Biffi
R.G. Backes
author_sort L. Moura
title Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_short Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_full Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_fullStr Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_full_unstemmed Development and evaluation of a novel subunit vaccine for Mycoplasma gallisepticum
title_sort development and evaluation of a novel subunit vaccine for mycoplasma gallisepticum
publisher Universidade Federal de Minas Gerais
series Arquivo Brasileiro de Medicina Veterinária e Zootecnia
issn 1678-4162
publishDate 2012-12-01
description Adhesion proteins from Mycoplasma gallisepticum (MG) encoded by cytadhesion genes mgc1 and mgc2 were cloned into plasmid vectors and transformed into E. coli. Seventeen groups of specific-pathogen free (SPF), birds at four weeks of age were used to inoculate these two proteins (MGC1 and MGC2) mixed into an oil emulsion creating a novel MG vaccine. Six different protein concentrations (50, 100, 200, 400, 800, and 1000µg/bird) were tested with two equal concentration doses at four and seven weeks of age. In addition, many control groups were needed such as bacterin, membrane, no vaccine or challenge, oil emulsion alone, and no vaccine but challenged. Three weeks following the second vaccination, 50% of the birds in each treatment group were challenged with MG strain S6. The remaining birds were left as contacts to verify protection against horizontal transmission. All birds were bled before vaccinations, challenge and euthanasia. Birds were negative for MG at the first vaccination, as shown by serum plate agglutination test. At necropsy, tissue samples (trachea, lungs, and air sacs) were collected for histopathological examination. Swabs from trachea were used for PCR analysis. ELISA results showed a strong immune response to both protein preparations and almost the same response level for different doses tested, proving the immunogenic features of MGC1 and MGC2. However, humoral responses failed to prevent MG infection and disease when challenged as demonstrated by PCR and histopathology. MGC1 contact birds showed some degree of infection by PCR analysis. In addition, histopathological and ELISA results suggest that contact birds did not have enough time to develop lesions and to mount an immune response.
topic avaliação
avicultura
desenvolvimento
micoplasmas
vacina
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352012000600024&lng=en&tlng=en
work_keys_str_mv AT lmoura developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
AT jdohms developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
AT jmalmeida developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
AT psferreira developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
AT cpbiffi developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
AT rgbackes developmentandevaluationofanovelsubunitvaccineformycoplasmagallisepticum
_version_ 1725093538467676160